Otero Ada Isis Pelaez, Fernandes Juliana Campos Hasse, Borges Tiago, Nassani Leonardo, Castilho Rogerio de Moraes, Fernandes Gustavo Vicentis de Oliveira
Faculty of Dental Medicine, Universidade Católica Portuguesa, 3504-505 Viseu, Portugal.
Private Clinic, 3505-606 Viseu, Portugal.
J Clin Med. 2022 Mar 28;11(7):1888. doi: 10.3390/jcm11071888.
The purpose of this systematic review was to analyze sinus lifting procedures and to compare the efficiency of this treatment associated with the second generation of platelet-rich fibrin related to its effects on bone gain and to clarify the regenerative efficacy in sinus lift procedure, whether alone or as a coadjutant to other bone graft materials. The PICOT question was, "In clinical studies with patients needing a maxillary sinus lift (P), does the use of PRF either alone (I) or in conjunction with other biomaterials (C) improve the clinical outcome associated with bone gain and density (O), with at least three months of follow-up (T)?" An electronic search was conducted in the MEDLINE (PubMed), Science Direct, and Scopus databases through a search strategy. A total of 443 articles were obtained from the electronic database search. Sixteen articles met all criteria and were included in this review. Within the limitation of this study and interpreting the results carefully, it was suggested that a higher risk for implant failure after a sinus elevation might be seen in patients with residual bone ≤4 mm, and PRF application was effective, suggesting reducing the time needed for new bone formation.
本系统评价的目的是分析上颌窦提升术,并比较第二代富血小板纤维蛋白在促进骨生长方面的治疗效果,以阐明上颌窦提升术中单独使用或与其他骨移植材料联合使用时的再生效果。PICOT问题为:“在需要进行上颌窦提升术的患者的临床研究中(P),单独使用富血小板纤维蛋白(I)或与其他生物材料联合使用(C)是否能改善与骨生长和骨密度相关的临床结局(O),且随访时间至少为三个月(T)?”通过检索策略在MEDLINE(PubMed)、Science Direct和Scopus数据库中进行了电子检索。从电子数据库检索中总共获得443篇文章。16篇文章符合所有标准并纳入本评价。在本研究的局限性范围内并仔细解释结果后,提示残余骨≤4 mm的患者在上颌窦提升术后种植体失败的风险可能更高,且应用富血小板纤维蛋白是有效的,这表明可缩短新骨形成所需的时间。